XenoGesis Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 40
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 5

XenoGesis General Information

Description

Provider of advising and laboratory-based research services intended to assist pharmaceutical clients engaged in drug discovery. The company's services specialize in preclinical metabolism, pharmacokinetics, quantitative bio-analysis and expert interpretation, enabling clients to get iterative feedback from the research team based on the results obtained by their researches.

Contact Information

Formerly Known As
Fully Integrated Pharma Solutions
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • BioCity Nottingham
  • Pennyfoot Street
  • Nottingham NG1 1GF
  • England, United Kingdom
+44 0115 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

XenoGesis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore XenoGesis‘s full profile, request access.

Request a free trial

XenoGesis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of advising and laboratory-based research services intended to assist pharmaceutical clients engaged in drug di
Drug Discovery
Nottingham, United Kingdom
40 As of 2020
00000
000000000000 00000

0000

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000 000000000
Dublin, Ireland
00000 As of 0000
00000
000000000 00000

0000000

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
0000 000000000
Ann Arbor, MI
00000 As of 0000
0000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

XenoGesis Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Icon Corporation Dublin, Ireland 00000 00000 000000000 00000
0000000 Private Equity-Backed Ann Arbor, MI 00000 0000000 0000
000000000 (00) Corporate Backed or Acquired Newport, United Kingdom 00 000000&0
You’re viewing 3 of 3 competitors. Get the full list »

XenoGesis Executive Team (6)

Name Title Board Seat Contact Info
Rebecca Denton Ph.D Chief Operating Officer
Graham Trevitt Ph.D Chief Scientific Officer
Dawn Parkins Founding Member & Director of Human Resource and Operations
John Dixon Ph.D Board Member, Drug Discovery Advisor & Business Development
You’re viewing 4 of 6 executive team members. Get the full list »

XenoGesis Board Members (3)

Name Representing Role Since
0000 00000 00.0 Self Board Member, Drug Discovery Advisor & Business Development 000 0000
You’re viewing 1 of 3 board members. Get the full list »

XenoGesis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XenoGesis Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore XenoGesis‘s full profile, request access.

Request a free trial